M83.4 Aluminum bone disease

Name of the Condition

• Aluminum bone disease

Summary

Aluminum bone disease is a metabolic bone disorder characterized by impaired bone mineralization due to aluminum accumulation, leading to weakened bone structure and increased fracture risk. It primarily affects individuals with chronic kidney disease or those exposed to aluminum-containing compounds.

Causes

Aluminum bone disease is caused by excessive aluminum accumulation in bone tissue, which disrupts normal mineralization. Common causes include prolonged exposure to aluminum-containing dialysate in patients undergoing hemodialysis, ingestion of aluminum-containing antacids or phosphate binders, or occupational exposure to aluminum compounds.

Risk Factors

• Chronic kidney disease, especially end-stage renal disease requiring dialysis.
• Prolonged use of aluminum-containing phosphate binders or antacids.
• Impaired aluminum excretion due to renal dysfunction.
• Occupational exposure to aluminum dust or fumes.
• Malnutrition or inadequate dietary intake of essential minerals.

Symptoms

• Diffuse bone pain, particularly in the hips, spine, or ribs.
• Muscle weakness or cramping.
• Increased susceptibility to fractures.
• Bone deformities in severe cases.
• Generalized discomfort or tenderness over bones.

Diagnosis

Diagnosis involves clinical evaluation of symptoms, blood tests to assess aluminum levels, and imaging (e.g., X-rays or bone density scans) to detect bone demineralization. Bone biopsy may be performed to confirm aluminum deposition in severe or unclear cases.

Treatment Options

Treatment focuses on reducing aluminum exposure and promoting bone healing. This may include discontinuing aluminum-containing medications, using chelation therapy to remove excess aluminum, and supplementing with calcium and vitamin D to support bone mineralization. Dialysis adjustments may be necessary for patients with renal impairment.

Prognosis and Follow-Up

Prognosis depends on the extent of bone damage and timely intervention. With appropriate treatment, bone mineralization may improve, reducing fracture risk. Regular monitoring of aluminum levels, bone density, and renal function is essential to prevent recurrence or progression.

Complications

• Increased risk of fractures, including hip or vertebral fractures.
• Chronic bone pain and functional impairment.
• Worsening of renal function in susceptible individuals.
• Delayed healing of bone injuries.

Lifestyle & Prevention

• Avoid aluminum-containing antacids or phosphate binders unless prescribed.
• Ensure adequate intake of calcium and vitamin D through diet or supplements.
• Follow renal diet guidelines if applicable.
• Limit occupational exposure to aluminum dust or fumes with proper protective measures.

When to Seek Professional Help

Seek medical attention if you experience persistent bone pain, unexplained fractures, or symptoms of muscle weakness, especially if you have a history of kidney disease or aluminum exposure.

Tips for Medical Coders

Document the underlying cause (e.g., chronic kidney disease, aluminum exposure) and any associated complications. Ensure clinical notes support the diagnosis, including laboratory or imaging findings. Code M83.4 is specific to aluminum bone disease; verify no other bone disorders are present that would require a different code.